Wegovy farts: what the evidence says and how to manage them

What the trial data actually recorded about gut symptoms

The STEP 1 trial (the 68-week registration study that formed the basis for Wegovy's UK licence) enrolled over 1,900 adults and tracked gastrointestinal events carefully. Nausea, diarrhoea, constipation, vomiting, and abdominal discomfort were the most frequently reported complaints, but flatulence and eructation (burping) appeared alongside them in the published safety data. The STEP 1 paper in the New England Journal of Medicine documents the full GI profile; the pattern is consistent across the semaglutide programme.

Two things stand out in the data. First, the rate of GI side effects was meaningfully higher in the semaglutide group than in the placebo group, which confirms these are drug-related effects rather than coincidental. Second, the events were mostly mild to moderate in severity and the majority resolved without the person stopping treatment. That matters: a side effect that is unpleasant for a few weeks is a very different clinical picture from one that is dangerous or lasting.

If you are curious how quickly Wegovy begins to produce its effects, the early weeks are also when GI symptoms tend to peak, the two timelines overlap for most people.

Why semaglutide produces extra wind in the first place

Wegovy works partly by slowing the rate at which the stomach empties its contents into the small intestine. This is useful for appetite control (you feel full for longer) but it also means food and liquid sit in the gut for an extended period. That extra time gives gut bacteria more opportunity to ferment undigested carbohydrates, and fermentation produces gas. The result, for many people, is more flatulence than usual.

There is a common misconception that the smell is particularly bad because of the drug itself acting on gut bacteria in some exotic way. The more straightforward explanation is that high-fat or high-fibre foods that might previously have moved through quickly are now spending longer in the colon. If you have noticed that the flatulence on Wegovy has a particularly unpleasant odour, diet rather than the drug itself is usually the more likely culprit. Whether the odour is noticeably worse varies from person to person and depends heavily on what is being eaten.

The NHS patient information for semaglutide lists flatulence and belching among the known side effects, which means your prescriber and pharmacist will not be surprised if you raise it. The NHS medicines page for semaglutide covers the full side-effect profile in plain language and is a good first reference.

Practical steps that make a real difference

Diet and eating behaviour have a larger influence than most people expect. A few adjustments tend to help:

Eating more slowly and chewing thoroughly reduces the amount of air swallowed with food, a straightforward source of gas that has nothing to do with semaglutide. Cutting back on carbonated drinks, chewing gum, and ultra-processed foods that contain artificial sweeteners (sorbitol, xylitol, mannitol) can reduce fermentation in the colon noticeably. Cruciferous vegetables, pulses, and onions are high fermenters; reducing portion sizes of these during the adjustment period rather than eliminating them entirely tends to work better long-term.

Timing matters too. Some people find that spreading food across smaller portions across the day, rather than two or three larger meals, produces less gas than letting the stomach fill and slow all at once. Hydration helps keep things moving.

If you are wondering how much extra wind is typical on Wegovy, the honest answer is that it varies widely. Some people notice very little change; others find the first few weeks genuinely uncomfortable. Neither experience invalidates the other.

For those exploring the cost of treatment alongside the physical experience of it, our Wegovy price comparison for the UK explains what legitimate private prescribing actually costs and what should be included in any quoted price.

When wind might signal something worth checking

Excess flatulence alone, even if persistent, is not an emergency. But there are circumstances where gut symptoms on Wegovy warrant a prompt call to your prescriber or GP rather than waiting it out.

Severe or persistent abdominal pain (particularly pain that is sharp, reaches the back, or comes with vomiting) should be assessed urgently because pancreatitis, though uncommon, is a known risk with GLP-1 medicines. The MHRA has issued specific guidance on this: the January 2026 Drug Safety Update highlighted acute pancreatitis as a serious but infrequent effect requiring prompt medical attention if symptoms arise. Pain of that character is different from the bloating and wind most people experience, but it is important to know the distinction.

Significant bloating accompanied by a sudden change in bowel habit, blood in stools, or unexplained weight loss (separate from the treatment's intended effect) should always be discussed with a clinician. These are not expected Wegovy side effects and deserve their own assessment.

For most people reading this page, flatulence on Wegovy is a nuisance rather than a warning sign. If you have specific concerns about how gut symptoms are affecting you, or if they are not settling after the first few weeks at a given dose, that is a straightforward conversation to have with a prescriber. Speak to our prescribers through a free consultation, a real clinician reads your notes the same day.